Estratest

Estratest is hormone replacement therapy drug that combines esterified estrogens with methyltestosterone in one pill.

Indications

Estratest is used to treat menopausal women who suffer from hot flashes but do not get relief from estrogen-only therapy

History

Estratest was first marketed in the United States in 1965 by Reid-Provident Laboratories, which as 100% of Reid-Rowell, Inc. stock was acquired by the Belgian pharmaceutical company Solvay in 1986. There has been some controversy surrounding the drug in recent years as to its status with the FDA.

Solvay is currently sponsoring a clinical trial of Estratest in the United States to determine whether the product is superior to treatment with esterified estrogens tablets

Dosage

Estratest is sold in tablet form, with either 1.25 mg estrogens/2.5 mg methyltestosterone or 0.625 mg estrogens/1.25 mg methyltestosterone available.

Supply

Estratest is supplied by Solvay.

References

• August 2003 press release from the Prescription Access Litigation project

External links

• The product's web site
• The clinical trial site